Matthew W. Jackson

Learn More
The addition of bevacizumab to established therapies for metastatic and locally advanced cervical cancer is an area of evolving research and a potential strategy toward improving historically suboptimal outcomes for women with advanced disease. Bevacizumab, when added to first-line chemotherapy, has now been shown to improve overall survival among women(More)
  • Carl Nadler, David Card, Bryan Graham, Patrick Kline, Eric Auerbach, Moshe Barach +18 others
  • 2016
Network-based connections are pervasive in hiring and mobility patterns. While the theoretical impacts of network connections on the inequality of labor market outcomes are well known (Calvo-Armengol and Jackson, 2004), the empirical magnitude of actual network effects is less certain. A key issue is the difficulty of disentangling the causal effect of(More)
Purpose. We performed a retrospective study to determine the outcome of a modern cohort of patients with high-grade (Gleason score ≥ 8) prostate cancer treated with radical prostatectomy, radiation therapy, or hormone therapy. Methods. We identified 404 patients in the South Texas Veteran's Healthcare System Tumor Registry diagnosed with high grade prostate(More)
  • 1